Serial Number
85441411
Owner
Industrial Research LimitedAttorney
Kevin S. CostanzaFiling Date
Oct 6, 2011
GLYCOSYN Trademark
Serial Number: 85441411 • Registration: 4315578
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Gracefield Road Gracefield Lower Hutt
Wellington , NZ
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
October 6, 2011
Registration Date
April 9, 2013
Published for Opposition
September 18, 2012
Goods & Services
Active pharmaceutical ingredients sold as an integral component of pharmaceutical preparations for the treatment of pain, inflammation, infection, diabetes, cancers and for wound repair; pharmaceutical ingredients used in enzyme replacement therapies, therapeutic vaccines (adjuvants), stem cell therapies, and for enhanced drug delivery; antioxidants; vaccines for the treatment of cancer; adjuvants and antigens for vaccines; active veterinary ingredients sold as an integral component of veterinary preparations for the treatment of bloat and for improving fecundity; herbicides and pesticides for commercial, agricultural or industrial use
Carbohydrate-derived chemicals and peptides for use in industry; chemical additives for use in the manufacture of pharmaceuticals and cosmetics
Scientific and technological research services in the fields of biotechnology, carbohydrate chemistry and pharmaceuticals including research services in the field of pharmaceutical and drug manufacture; biological, pharmaceutical and medical research; testing services, namely, testing, inspection or research of pharmaceuticals and drugs; laboratory services, namely, chemical synthesis of active pharmaceutical intermediates (APIs) for use in pre-clinical and human clinical trials; pharmaceutical research and development services, namely, active pharmaceutical intermediates (APIs) research and development to support pre-clinical and early phase human clinical trials; chemical laboratory analytical services, namely, analyzing pharmaceuticals and potential pharmaceutical ingredients
